Growth Investment for the Future, Including R&D and Personnel Expenses
First written in FY2019-Q3. 15 of 18 entries say "Restated". Latest entry: FY2026.
54 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Research and development expenses for the current consolidated fiscal year were ¥1,476 million. By segment, research and development expenses were ¥1,413 million in Japan and ¥62 million in Asia.」
The Company continued its research and development activities and recorded research and development expenses of ¥1,476 million. Development progressed to prototypes of 9 GHz coaxial WtoB connectors, power-expandable BtoB connectors, 60A floating busbar sockets and IP67-compatible FPC-to-FPC connectors. - FY2026-H1RestatedAnnual report
「The Group's total R&D expenditure for the interim consolidated accounting period was ¥806 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The Company continued its research and development activities as part of its growth investment for the future and reported research and development expenses of ¥806 million for the interim consolidated accounting period. - FY2024-Q3RestatedAnnual report
「The Group's total research and development activities amounted to ¥968 million during the third-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the third-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥968 million for the third-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2024-Q2RestatedAnnual report
「The Group's total research and development activities amounted to ¥641 million during the second-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the second-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥641 million for the second-quarter consolidated cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2024-Q1RestatedAnnual report
「The Group's total research and development activities amounted to ¥315 million during the first-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the first-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥315 million for the first-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2023-Q3RestatedAnnual report
「The Group's total research and development activities amounted to ¥939 million during the third-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the third-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥939 million for the third-quarter consolidated cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2023-Q2RestatedAnnual report
「The Group's total research and development activities amounted to ¥632 million during the second-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the second-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥632 million for the second-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2022-Q3RestatedAnnual report
「The Group's total research and development activities amounted to ¥992 million during the third-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the third-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥992 million for the third-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2022-Q2RestatedAnnual report
「The Group's total research and development activities amounted to ¥689 million during the second-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the second-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥689 million for the second-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2022-Q1RestatedAnnual report
「The Group's total research and development activities amounted to ¥323 million during the first-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the first-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥323 million for the first-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2021RestatedAnnual report
「Research and development expenses for the consolidated fiscal year amounted to ¥1,208 million. By segment, research and development expenses were ¥1,165 million in Japan and ¥42 million in Asia.」
The Company continued its research and development activities and reported research and development expenses of ¥1,208 million for the fiscal year. - FY2021-Q3RestatedAnnual report
「The Group's total research and development activities amounted to ¥915 million during the third-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the third-quarter consolidated cumulative period.」
The Company reported research and development expenses of ¥915 million for the third-quarter consolidated cumulative period and reconfirmed that there were no material changes in the status of its research and development activities. - FY2021-Q2RestatedAnnual report
「The Group's total research and development activities amounted to ¥641 million during the second-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the second-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥641 million for the second-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2021-Q1RestatedAnnual report
「The Group's total research and development activities amounted to ¥363 million during the first-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the first-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported first-quarter research and development expenses of ¥363 million. It stated that there were no material changes in the status of its research and development activities. - FY2020-Q3RestatedAnnual report
「The Group's total research and development activities amounted to ¥1,090 million during the third-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the third-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported research and development expenses of ¥1,090 million for the third-quarter consolidated cumulative period. It stated that there were no material changes in the status of those activities. - FY2020-Q1RestatedAnnual report
「The Group's total research and development activities amounted to ¥384 million during the first-quarter consolidated cumulative period. There were no material changes in the status of the Group's research and development activities during the first-quarter consolidated cumulative period.」
The Company continued its research and development activities and reported first-quarter research and development expenses of ¥384 million, while stating that there were no material changes in the status of those activities. - FY2019AdvancedAnnual report
「Operating profit declined because, although the Nantong plant in China (Nantong Yilisu Electronic Industrial Co., Ltd.) began operations in April as part of the "strengthening production capacity" initiative under the medium-term management plan, production volumes could not be secured due to the market slowdown, while spending on growth investment for the future, including research and development expenses and personnel costs, increased.」
In addition to launching the Nantong plant, spending on growth investment for the future, including research and development expenses and personnel costs, increased and became a factor behind the decline in operating profit. - FY2019-Q3First statedAnnual report
「Operating profit declined as the Company continued to invest in growth. As part of the "strengthening production capacity" initiative under its medium-term management plan, its Nantong plant in China (Nantong Yilisu Electronic Industrial Co., Ltd.) began operations in April and incurred start-up costs. Investment in the future, including research and development expenses and personnel costs, also increased.」
The Company explained that, in addition to launching the Nantong plant, it continued to expand investment in the future, including research and development expenses and personnel costs, and that the resulting increase was a factor behind the decline in operating profit in the third quarter.